Related Experiment Videos
Inhibition of murine tumor development by the lectin wheat germ agglutinin
Abstract:
The antitumor activity of lectins were examined by studying the effect of lectins on the in vivo growth of murine tumors. The lectin wheat germ agglutinin (WGA) inhibited the growth of MM46 ascites tumors in vivo as effectively as syngeneic antitumor antiserum, but other lectins were not effective in vivo. WGA also had an inhibitory effect on other syngeneic and allogeneic ascites tumors, a fact which is consistent with its wide range of target tumor cells demonstrated in the in vitro cytolysis system. These results suggest that WGA is a better antitumor agent than other plant lectins. The therapeutic effect of WGA might be, in part, due to its ligand activity between tumor cells and macrophages that induces lectin-dependent macrophage-mediated cytolysis, in addition to its direct cytostatic activity.
Insights
Wheat germ agglutinin (WGA) shows significant antitumor activity against murine tumors, outperforming other lectins. WGA
Area of Science:
- Immunology
- Biochemistry
- Oncology
Background:
- Lectins, carbohydrate-binding proteins, have potential therapeutic applications.
- Understanding lectin interactions with tumor cells is crucial for developing novel cancer treatments.
Purpose of the Study:
- To evaluate the in vivo antitumor activity of various lectins.
- To determine the efficacy of wheat germ agglutinin (WGA) against murine tumors.
- To elucidate the mechanisms underlying WGA's antitumor effects.
Main Methods:
- In vivo studies of lectin effects on murine tumor growth.
- Assessment of WGA's inhibitory activity on different syngeneic and allogeneic ascites tumors.
- In vitro cytolysis assays to identify target tumor cells for WGA.
Main Results:
- Wheat germ agglutinin (WGA) demonstrated significant inhibition of MM46 ascites tumor growth in vivo.
- WGA showed efficacy against a range of syngeneic and allogeneic ascites tumors.
- Other tested lectins exhibited limited or no in vivo antitumor activity.
Conclusions:
- WGA is a promising antitumor agent compared to other plant lectins.
- WGA's therapeutic effect may involve direct cytostatic activity and lectin-dependent macrophage-mediated cytolysis.
- WGA's broad-spectrum activity suggests potential for diverse cancer therapies.